Skip to main content

Table 1 General demographic, clinical and neuropathological characteristics of the subjects included in this study

From: Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein

Groups

Number of cases

Male/Female

Age (years)

PMD (hours)

Subjects with a normal neuropathological examination

27

19/8

70 (65–75)

6 (3–8)

Subjects with a normal neuropathological examination and T2DM

19

11/8

lg

6 (4–8)

AD with low neuropathologic change

28

14/14

77 (73–81)

6 (4–8)

AD with intermediate neuropathologic change

26

11/15

78 (75–82)

5 (4–6)

AD with high neuropathologic change

8

3/5

83 (76–92)

5 (3–6)

Incidental Lewy body disease

8

7/1

71 (66–76)

7 (6–8)

Parkinson's disease

10

5/5

77 (74–82)

6 (5–8)

Dementia with Lewy bodies

12

9/3

82 (76–88)

6 (5–8)

  1. The data are the median (25th/75th percentiles) or n (%): PD, Parkinson’s disease; DLB, dementia with Lewy bodies; ILBD, incidental Lewy body disease; AD, Alzheimer’s disease; T2DM, type two diabetes mellitus; PMD, postmortem delay